Jiesen tries to take over the world

[jiesen]

1% position in Large-cap index fund purchased today

just sold about a 1% position in a large-cap index fund today, and am waiting for a big pullback (15-20%) to buy back in with 2%.

Just bought that 1% position back today, at about 8-9% below where I sold it a couple months ago. The market hasn't pulled back quite as far yet as I think it will, but we could very well see a rally in the meantime, and I'd like to make a quick buck or two off of that if possible... Still waiting for a pullback to a Nasdaq 2200 or so to buy back the rest of this position.

[jiesen]

Sold GFCI for a penny

My limit was hit yesterday at about 0.01 for GFCI.PK. I bought in for 0.2, so lost about 95% on this, but I wanted to sell now so I'd have an offsetting loss for my taxable GPRO gains this year. I'm not expecting GFCI to ever be back over a nickel again anyway, and at 0.01 I can at least still pay for the commission on the trade...

[jiesen]

Just did my analysis. I'll wait a while longer. better prices are yet to come.

You're probably right. The trial will take time to produce the results, and all they do during that time is spend money...

[Websman]

I'm thinking about intitianting a position in LJPC here. This thing has been beat down pretty good.

Just did my analysis. I'll wait a while longer. better prices are yet to come.

[Websman]

I'm thinking about intitianting a position in LJPC here. This thing has been beat down pretty good.

[Websman]

just sold about a 1% position in a large-cap index fund today, and am waiting for a big pullback (15-20%) to buy back in with 2%.

Probably not a bad move Jiesen...

So wassup?

[jiesen]

Selling the rally...

just sold about a 1% position in a large-cap index fund today, and am waiting for a big pullback (15-20%) to buy back in with 2%.

[jiesen]

Sold GPRO

sold half of my GPRO stock today at 60.0 for a 35% profit.

Sold a 2% position at 68 today, still have a few shares left as pure profit.

[jiesen]

sorry, Billyjoe... no I don't know anything about it. I tried to give it a decent look, but unfortunately have been too busy lately to give it any more than a glance. Things will hopefully settle down a bit in a month or two for me, but for now I can only say that if you want to put money in stem cell research, your best bets are probably ASTM and STEM. They should both get a decent pop the next time the Governator makes more promises to give money to SS research (which funds arguably may still never make it into a commercial lab, after the state bureaucrats get through with it). Also, for gene-on-a-chip technology (among other products) I'd recommend going with ILMN instead.

This outfit (WGBS) seems likely to run outta steam before getting anything on the market- but again, I've only taken a very quick look. I'll try again to take a better look, but I believe this is one you can take your time to evaluate, as it's likely to keep getting cheaper in the short-term.

[billyjoe]

Jiesen,
Do you know anything about WGBS? Do they really have a dynamite product that will revolutionize DNA research?

--------------billyjoe

[jiesen]

flip-flopped on LJPC

picked the shares up again and then some at 3.9

[jiesen]

Sold 1% LJPC

sold those shares today at 4.0 for about a 2% loss. I'll try to pick it back up again later at a lower price.

[jiesen]

Bought LJPC at 4.1

added another 1% to my ~20% position in LJPC today at 4.1

[jiesen]

New investor for LJPC - Fouad El Adli

Looks like a molecular biologist/poker player has just put his $10M into LJPC:

http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_L/threadview?m=tm&bn=10714&tid=59922&mid=59931&tof=4&rt=2&frt=2&off=1

How many more of these purchases does LJPC need to soak up the remaining float? Won't take much now to send this stock soaring...

[jiesen]

Heya Billyjoe...

Yeah, TUNE is the story of my life... just didn't have the patience to see it through, would have been pretty good so far, probably still has a ways to go. It seems my patience lasts for the stinkers more often than the winners. Wonder why that is?

Anyway, as for ESMC:

On the surface it looks pretty good, especially with the recent revenue increase (about $10M). Of course on closer inspection that turns out to be a one-time settlement of a lawsuit with Interlase.

This is not a company that $$MM would be comfortable buying- last year they lost $2M.

Still, to me it's interesting, since they did get a recent FDA approval of a glucose analyzer- this should help grow the earnings in the future. The stock seems to be responding well to the news, and it's still more or less inexpensive.

http://finance.yahoo.com/q/bc?s=ESMC&t=1y

Consider that the market cap is $46M*, and the net assets for the company are about $20M. If they can get enough business from this new contraption to generate, say, $4M or so in NET income next year, I'd say it's currently priced at a bargain at $7/shr. Wouldn't be too much of a stretch, considering a couple years ago they were making about $2.5M. But that's where you'd want to do your homework, make sure they're not just going to blow the incoming revenue on wasteful projects. I suggest further reading of the 10-Q filings until you're confident they have a good strategy for making that money before putting up the cash.

http://yahoo.brand.edgar-online.com/fetchFilingFrameset.aspx?dcn=0000893220-07-001916&Type=HTML

(it's interesting to note that the CEO hired his son and daughter-in-law for $200K total in consulting)

Also consider, glucose monitoring, creatinine, nitrogen analysis- these aren't all that special or difficult to do- barriers to entry aren't so high here, so ESMC probably won't be able to make tons of money off of this latest device. They'll need to have better things in development for future income. Look for a long-term plan with this guy as well.

Good luck with it if you decide to buy!

*And definitely double-check the $46M market cap I pulled from the Yahoo! Finance data, which is quite often incorrect (but always free), before making any investment decision based on it.